Cargando…
Genome editing for sickle cell disease: still time to correct?
Sickle cell disease (SCD) is an inherited blood disorder, due to a single point mutation in the β-globin gene (HBB) leading to multisystemic manifestations and it affects millions of people worldwide. The monogenic nature of the disease and the availability of autologous hematopoietic stem cells (HS...
Autores principales: | Ceglie, Giulia, Lecis, Marco, Canciani, Gabriele, Algeri, Mattia, Frati, Giacomo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652763/ https://www.ncbi.nlm.nih.gov/pubmed/38027257 http://dx.doi.org/10.3389/fped.2023.1249275 |
Ejemplares similares
-
Changes in Urine Microalbumin-to-Creatinine Ratio in Children with Sickle Cell Disease over Time
por: Shatat, Ibrahim F., et al.
Publicado: (2016) -
Inflammatory status in pediatric sickle cell disease: Unravelling the role of immune cell subsets
por: Marchesani, Silvio, et al.
Publicado: (2023) -
Bispecific Antibodies and Other Non-CAR Targeted Therapies and HSCT: Decreased Toxicity for Better Transplant Outcome in Paediatric ALL?
por: Kállay, Krisztián Miklós, et al.
Publicado: (2022) -
Hematopoietic Cell Transplantation for Sickle Cell Disease
por: Krishnamurti, Lakshmanan
Publicado: (2021) -
Editing a γ-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype
por: Weber, Leslie, et al.
Publicado: (2020)